Chi Sheng Pharma & Biotech Co., Ltd (TPEX:4111)

Taiwan · Delayed Price · Currency is TWD

30.10

+0.15 (0.50%)

Aug 19, 2026, 1:30 PM CST

-5.94% (1Y)

Market Cap	1.80B -4.8%
Revenue (ttm)	1.42B +9.0%
Net Income	189.07M +34.7%
EPS	3.13 +34.7%
Shares Out	59.83M
PE Ratio	9.62
Forward PE	n/a
Dividend	1.30 (4.34%)
Ex-Dividend Date	Aug 25, 2026

Volume	217,505
Open	29.80
Previous Close	29.95
Day's Range	29.70 - 30.20
52-Week Range	28.85 - 32.90
Beta	0.20
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 10, 2026

About TPEX:4111

Chi Sheng Pharma & Biotech Co., Ltd manufactures, processes, imports, exports, and sells western medicines, cosmetics, health food products, medical devices, and animal medicines in Taiwan and internationally. Its product portfolio includes antibiotics and chemotherapeutic agents; plasma substitutes and amino acid preparations; water nutrients and electrolyte preparations; vitamins; hepatotropic agents; hormones and adrenal cortical steroids; autonomic nerve agents; antihistamines and antipruritics; antipyretics and analgesics; antitussives and... [Read more]

Industry Medical Instruments & Supplies

Sector Healthcare

Founded 1962

Country Taiwan

Stock Exchange Taipei Exchange

Ticker Symbol 4111

Full Company Profile

Financial Performance

In 2025, TPEX:4111's revenue was 1.38 billion, an increase of 18.11% compared to the previous year's 1.17 billion. Earnings were 164.28 million, an increase of 48.49%.

Financial Statements